Chemocentryx reported $315.89M in Equity Capital and Reserves for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Equity Capital And Reserves Change
Alexion Pharmaceuticals ALXN:US $ 12416.8M 765.6M
Alnylam Pharmaceuticals ALNY:US $ 755.89M 97.47M
Amgen AMGN:US $ 8217M 30M
AstraZeneca AZN:LN 39744M 24068M
Bayer BAYN:GR € 31103M 714M
Biogen BIIB:US $ 10429.9M 322M
Biomarin Pharmaceutical BMRN:US $ 4266.15M 24.58M
Bristol Myers Squibb BMY:US $ 37213M 405M
Chemocentryx CCXI:US $ 315.89M 14.38M
GlaxoSmithKline GSK:LN 15426M 49M
Glaxosmithkline GSK:US $ 15426M 49M
Macrogenics MGNX:US $ 291.44M 27.61M
Mirati Therapeutics MRTX:US $ 1084.03M 44.9M
Novartis NOVN:VX SF 56771M 2729M
Omeros OMER:US $ -262697000 16.4M
Sarepta Therapeutics SRPT:US $ 469.53M 15.58M
Takeda 4502:JP Y 5323935M 24161M
Teva Pharmaceutical TEVA:IT 10.47B 143M
YTE INCY:US $ 3148.66M 212.8M